Ceribell, Inc. (CBLL): Total Assets
$195.80M
As of 2025-12-31
$166.35M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $195.80M | -13.1% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $225.41M | +282.6% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $58.92M | n/a | 2025-02-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | 2025-12-31 | $195.80M | -13.1% |
| Vaso Corp (VASO) | 2025-12-31 | $88.35M | +6.5% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $405.88M | +1.6% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $66.27M | +23.2% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $264.50M | -4.1% |
| Iridex Corp (IRIX) | 2026-01-03 | $29.15M | +0.1% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $221.69M | +8.8% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $52.25M | +11.8% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $18.67M | -8.8% |
Compare CBLL, VASO, BLFS, ELMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗